We did not observe SARS-CoV-2 spike S2 binding with p53 in cancer cells using immunoprecipitation assay as previously predicted through an in-silico study showing that the S2 subunit of SARS-CoV-2 spike may interact with p53 [6]. This evidence concerns the gene TP53 and cancer.